{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:09:01Z","timestamp":1787242141547,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00127-016-1259-7","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T04:11:15Z","timestamp":1466741475000},"page":"1623-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study"],"prefix":"10.1007","volume":"51","author":[{"given":"Stefanie N.","family":"Rezansoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moniruzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Procyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","volume":"176","author":"D Novick","year":"2010","unstructured":"Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM (2010) Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 176:109\u2013113. doi: 10.1016\/j.psychres.2009.05.004","journal-title":"Psychiatry Res"},{"key":"1259_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4088\/JCP.v67n0317","volume":"67","author":"H Ascher-Svanum","year":"2006","unstructured":"Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 67:453\u2013460. doi: 10.4088\/JCP.v67n0317","journal-title":"J Clin Psychiatry"},{"key":"1259_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1176\/appi.ps.201400506","volume":"66","author":"ZS Predmore","year":"2015","unstructured":"Predmore ZS, Mattke S, Horvitz-Lennon M (2015) Improving antipsychotic adherence among patients with schizophrenia: savings for states. Psychiatr Serv 66:343\u2013345. doi: 10.1176\/appi.ps.201400506","journal-title":"Psychiatr Serv"},{"key":"1259_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.psychres.2014.11.002","volume":"225","author":"KV Sendt","year":"2015","unstructured":"Sendt KV, Tracy DK, Bhattacharyya S (2015) A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Res 225:14\u201330. doi: 10.1016\/j.psychres.2014.11.002","journal-title":"Psychiatry Res"},{"key":"1259_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS (2011) Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008. Pharmacoepidemiol Drug Saf 20:177\u2013184. doi: 10.1002\/pds.2082","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1259_CR6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201500316","author":"J Driessen","year":"2016","unstructured":"Driessen J, Baik SH, Zhang Y (2016) Trends in off-label use of second-generation antipsychotics in the Medicare population from 2006 to 2012. Psychiatr Serv. doi: 10.1176\/appi.ps.201500316","journal-title":"Psychiatr Serv"},{"key":"1259_CR7","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1185\/03007990903126833","volume":"25","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25:2303\u20132310. doi: 10.1185\/03007990903126833","journal-title":"Curr Med Res Opin"},{"key":"1259_CR8","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2013.1113","author":"SJ Rolnick","year":"2013","unstructured":"Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ (2013) Patient characteristics associated with medication adherence. Clin Med Res. doi: 10.3121\/cmr.2013.1113","journal-title":"Clin Med Res"},{"key":"1259_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1176\/ps.62.9.pss6209_1032","volume":"62","author":"KL Rascati","year":"2015","unstructured":"Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M (2015) Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv 62:1032\u20131040. doi: 10.1176\/ps.62.9.pss6209_1032","journal-title":"Psychiatr Serv"},{"key":"1259_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050225","author":"S Fazel","year":"2008","unstructured":"Fazel S, Khosla V, Doll H, Geddes J (2008) The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Med. doi: 10.1371\/journal.pmed.0050225","journal-title":"PLoS Med"},{"key":"1259_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/2150131914560610","author":"CE Hunter","year":"2014","unstructured":"Hunter CE, Palepu A, Farrell S, Gogosis E, O\u2019Brien K, Hwang SW (2014) Barriers to prescription medication adherence among homeless and vulnerably housed adults in three Canadian cities. J Prim Care Community Health. doi: 10.1177\/2150131914560610","journal-title":"J Prim Care Community Health"},{"key":"1259_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","volume":"161","author":"TP Gilmer","year":"2004","unstructured":"Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV (2004) Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 161:692\u2013699. doi: 10.1176\/appi.ajp.161.4.692","journal-title":"Am J Psychiatry"},{"key":"1259_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","volume":"8","author":"M Sajatovic","year":"2006","unstructured":"Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV (2006) Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 8:232\u2013241. doi: 10.1111\/j.1399-5618.2006.00314.x","journal-title":"Bipolar Disord"},{"key":"1259_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10597-015-9904-2","volume":"52","author":"E Hermes","year":"2015","unstructured":"Hermes E, Rosenheck R (2015) Psychopharmacologic services for homeless veterans: comparing psychotropic prescription fills among homeless and non-homeless veterans with serious mental illness. Community Ment Health J 52:142\u2013147. doi: 10.1007\/s10597-015-9904-2","journal-title":"Community Ment Health J"},{"key":"1259_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11414-013-9329-z","volume":"40","author":"J Lin","year":"2013","unstructured":"Lin J, Wong B, Offord S, Mirski D (2013) Healthcare cost reductions associated with the use if LAI formulations of antipsychotic medications among patients with schizophrenia. J Behav Health Serv Res 40:355\u2013366. doi: 10.1007\/s11414-013-9329-z","journal-title":"J Behav Health Serv Res"},{"key":"1259_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2010.11.020","volume":"127","author":"C Leucht","year":"2011","unstructured":"Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (2011) Oral versus depot antipsychotic drugs for schizophrenia: a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res 127:83\u201392. doi: 10.1016\/j.schres.2010.11.020","journal-title":"Schizophr Res"},{"key":"1259_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/schbul\/sbs150","volume":"40","author":"T Kishimoto","year":"2012","unstructured":"Kishimoto T, Robenzadeh A, Leucht C, Leucht S, Watanabe K, Mimura M, Borenstein M, Kane J, Correll CU (2012) Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophr Bull 40:192\u2013213. doi: 10.1093\/schbul\/sbs150","journal-title":"Schizophr Bull"},{"key":"1259_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/YIC.0b013e32835b091f","volume":"28","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Kempton MJ, Rosenheck RA (2013) Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials. Int Clin Psychopharmacol 28:57\u201366. doi: 10.1097\/YIC.0b013e32835b091f","journal-title":"Int Clin Psychopharmacol"},{"key":"1259_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamapsychiatry.2015.0270","volume":"72","author":"KL Subotnik","year":"2015","unstructured":"Subotnik KL, Casaus LR, Ventura J, Luo JS, Hellemann GS, Gretchen-Doorly D, Marder S, Nuechterlein KH (2015) Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial. JAMA Psychiatry 72:822\u2013829. doi: 10.1001\/jamapsychiatry.2015.0270","journal-title":"JAMA Psychiatry"},{"key":"1259_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/YIC.0000000000000082","volume":"30","author":"CA Bossie","year":"2015","unstructured":"Bossie CA, Alphs LD, Correll CU (2015) Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs. Int Clin Psychopharmacol 30:272\u2013281. doi: 10.1097\/YIC.0000000000000082","journal-title":"Int Clin Psychopharmacol"},{"key":"1259_CR21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4088\/JCP.12m08331","volume":"74","author":"M Sajatovic","year":"2013","unstructured":"Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C, Bialko CS, Cassidy KA, Fuentes-Casiano E, Williams TD (2013) A prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. J Clin Psychiatry 74:1249\u20131255. doi: 10.4088\/JCP.12m08331","journal-title":"J Clin Psychiatry"},{"key":"1259_CR22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.schbul.a007076","volume":"30","author":"M Valenstein","year":"2004","unstructured":"Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham R, Stavenger T (2004) Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 30:255\u2013264","journal-title":"Schizophr Bull"},{"key":"1259_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10597-014-9697-8","volume":"50","author":"I Vassileva","year":"2014","unstructured":"Vassileva I, Milanova V, Asan T (2014) Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia. Community Ment Health J 50:854\u2013861. doi: 10.1007\/s10597-014-9697-8","journal-title":"Community Ment Health J"},{"key":"1259_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120560","author":"T Eticha","year":"2015","unstructured":"Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A (2015) Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PloS One. doi: 10.1371\/journal.pone.0120560","journal-title":"PloS One"},{"key":"1259_CR25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","volume":"63","author":"JP Lacro","year":"2002","unstructured":"Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892\u2013909","journal-title":"J Clin Psychiatry"},{"key":"1259_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbtep.2008.02.003","volume":"40","author":"HW Tsang","year":"2009","unstructured":"Tsang HW, Fung KM, Corrigan PW (2009) Psychosocial and socio demographic correlates of medication compliance among people with schizophrenia. J Behav Ther Exp Psychiatry 40:3\u201314. doi: 10.1016\/j.jbtep.2008.02.003","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"1259_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/schbul\/sbp121","volume":"37","author":"M Valenstein","year":"2011","unstructured":"Valenstein M, Kavanagh J, Lee T, Reilly P, Dalack GW, Grabowski J, Smelson D, Ronis DL, Ganoczy D, Woltmann E, Metreger T, Wolschon P, Jensen A, Poddig B, Blow F (2011) Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull 37:727\u2013736. doi: 10.1093\/schbul\/sbp121","journal-title":"Schizophr Bull"},{"key":"1259_CR28","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.euroneuro.2015.04.003","volume":"25","author":"P Czobor","year":"2015","unstructured":"Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischacker WW, Volavka J (2015) Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol 25:1158\u20131166. doi: 10.1016\/j.euroneuro.2015.04.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"1259_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3109\/00048674.2010.493503","volume":"44","author":"D Dassa","year":"2010","unstructured":"Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T (2010) Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry 44:921\u2013928. doi: 10.3109\/00048674.2010.493503","journal-title":"Aust N Z J Psychiatry"},{"key":"1259_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1745-6215-14-365","volume":"14","author":"JM Somers","year":"2013","unstructured":"Somers JM, Patterson ML, Moniruzzaman A, Currie L, Rezansoff SN, Palepu A, Fryer K (2013) Vancouver At Home: pragmatic randomized trials investigating housing first for homeless and mentally ill adults. Trials 14:365\u2013385. doi: 10.1186\/1745-6215-14-365","journal-title":"Trials"},{"key":"1259_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1345\/aph.1K385","volume":"42","author":"K Dahri","year":"2008","unstructured":"Dahri K, Shalansky SJ, Jang L, Jung L, Ignaszewski AP, Clark C (2008) Accuracy of a provincial prescription database for assessing medication adherence in heart failure patients. Ann Pharmacother 42:361\u2013367. doi: 10.1345\/aph.1K385","journal-title":"Ann Pharmacother"},{"key":"1259_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1472-6963-12-155","volume":"12","author":"WM Vollmer","year":"2012","unstructured":"Vollmer WM, Xu M, Feldstein A, Smith D, Waterbury A, Rand C (2012) Comparison of pharmacy-based measures of medication adherence. BMC Health Serv Res 12:155\u2013162. doi: 10.1186\/1472-6963-12-155","journal-title":"BMC Health Serv Res"},{"key":"1259_CR33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00005650-198808000-00007","volume":"26","author":"JF Steiner","year":"1988","unstructured":"Steiner JF, Koepsell TD, Finn SD, Inui TS (1988) A general method of compliance assessment using centralized pharmacy records. Med Care 26:814\u2013823","journal-title":"Med Care"},{"key":"1259_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","volume":"55","author":"PJ Weiden","year":"2004","unstructured":"Weiden PJ, Kozma C, Grogg A, Locklear J (2004) Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 55:886\u2013891. doi: 10.1176\/appi.ps.55.8.886","journal-title":"Psychiatr Serv"},{"key":"1259_CR35","unstructured":"National Institute for Health and Care Excellence (2014) Psychosis and schizophrenia in adults: prevention and management. National Clinical Guideline Number 178. https:\/\/www.nice.org.uk\/guidance\/cg178 . Accessed 3 Jan 2016"},{"key":"1259_CR36","doi-asserted-by":"publisher","first-page":"S1171","DOI":"10.1016\/S0924-9338(09)71404-X","volume":"24","author":"D Mittal","year":"2009","unstructured":"Mittal D, Owen RR, Lacro JP (2009) Antipsychotic adherence intervention for veterans over 40 with schizophrenia: results of a pilot study. Clin Schizophr Relat Psychoses 24:S1171\u2013S1181. doi: 10.1016\/S0924-9338(09)71404-X","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"1259_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12942","author":"M Alili El","year":"2016","unstructured":"El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M (2016) A scoping review of studies comparing the medication event monitoring system (MEMS) with alternate methods for measuring medication adherence. Br J Clin Pharmacol. doi: 10.1111\/bcp.12942","journal-title":"Br J Clin Pharmacol"},{"key":"1259_CR38","volume-title":"IBM SPSS statistics for windows, version 22.0","author":"Corp IBM. Released","year":"2013","unstructured":"Corp IBM. Released (2013) IBM SPSS statistics for windows, version 22.0. IBM Corp, Armonk"},{"key":"1259_CR39","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4088\/JCP.v67n1008","volume":"67","author":"M Valenstein","year":"2006","unstructured":"Valenstein M, Ganoczy D, McCarthy JF, Myra KH, Lee TA, Blow FC (2006) Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 67:1542\u20131550","journal-title":"J Clin Psychiatry"},{"key":"1259_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1176\/appi.ps.201100543","volume":"64","author":"M Valenstein","year":"2013","unstructured":"Valenstein M, McCarthy JF, Ganoczy D, Bowersox NW, Dixon LB, Miller R, Visnic S, Slade EP (2013) Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medication. Psychiatr Serv 64:445\u2013451. doi: 10.1176\/appi.ps.201100543","journal-title":"Psychiatr Serv"},{"key":"1259_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamapsychiatry.2015.0485","volume":"72","author":"WT Carpenter","year":"2015","unstructured":"Carpenter WT, Buchanan RW (2015) Expanding therapy with long-acting antipsychotic medication in patients with schizophrenia. JAMA Psychiatry 72:745\u2013746. doi: 10.1001\/jamapsychiatry.2015.0485","journal-title":"JAMA Psychiatry"},{"key":"1259_CR42","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/088740341305805s02","volume":"58","author":"R Manchanda","year":"2013","unstructured":"Manchanda R, Chue P, Tibbo Roy MA, Williams R (2013) Long-acting injectable antipsychotics: evidence of effectiveness and use. Can J Psychiatry 58:5S\u201313S","journal-title":"Can J Psychiatry"},{"key":"1259_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0447.2006.00757.x","volume":"430","author":"R Williams","year":"2006","unstructured":"Williams R, Kopala L, Malla A, Smith G, Love L, Balshaw R (2006) Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia. Acta Psychiatr Scand Suppl 430:12\u201321. doi: 10.1111\/j.1600-0447.2006.00757.x","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"1259_CR44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/1472-6963-14-404","volume":"14","author":"LB Currie","year":"2014","unstructured":"Currie LB, Patterson ML, Moniruzzaman A, McCandless LC, Somers JM (2014) Examining the relationship between health-related need and the receipt of care by participants experiencing homelessness and mental illness. BMC Health Serv Res 14:404\u2013414. doi: 10.1186\/1472-6963-14-404","journal-title":"BMC Health Serv Res"},{"key":"1259_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/PPA.S41609","volume":"7","author":"T Dilla","year":"2013","unstructured":"Dilla T, Ciudad A, Alvarez M (2013) Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence 7:275\u2013284. doi: 10.2147\/PPA.S41609","journal-title":"Patient Prefer Adherence"},{"key":"1259_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0758-0","author":"JM Somers","year":"2016","unstructured":"Somers JM, Moniruzzaman A, Currie L, Rezansoff S, Russolillo A, Parpopuchi M (2016) Accuracy of reported service use in a cohort of people who are chronically homeless and mentally ill. BMC Psychiatry. doi: 10.1186\/s12888-016-0758-0","journal-title":"BMC Psychiatry"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-016-1259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00127-016-1259-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-016-1259-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:02:02Z","timestamp":1498309322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00127-016-1259-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s00127-016-1259-7","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}